T his is one of the few pieces I have written that does not focus on the evolution, the systematics, the fascinating complexity of the biological world. I am stepping out of my usual arena because I feel it is important that we develop a new sense of the role and importance of public policy in our professional societies. There are many working in the area of public policy who can write with much more authority than I can about what can be achieved with professional public policy officers. But I offer a different perspective, one developed as an active society participant. I developed the following views based on experiences as an officer in several societies (all of them AIBS members), in particular, as the representative of the Botanical Society of America, and subsequently of AIBS, on the Council of Scientific Society Presidents (CSSP).
From my experience in CSSP with a broad spectrum of science society presidents, I can tell you that chemists, physicists, molecular biologists, and, of course, biomedical researchers are leagues ahead of organismal and integrative biologists in making their cases and in promoting their fields to the general public and to state and federal legislatures and regulatory agencies. Their successes persuade me that AIBS member societies and organizations, now numbering more than 80, with a combined membership of more than 240,000 biologists, must combine forces to offer more effective advocacy for organismal and integrative biology. We are facing more-and ever more complex-challenges everyday; our opponentssuch as those leading the attacks on the teaching of evolutionare increasingly more organized and sophisticated. To protect our own interests, we must act in concert.
There is no doubt that public officials at the highest levels recognize the importance of biology. The late legislative advocate of science, California Congressman George Brown, commented that National Science Foundation Director Rita Colwell's "career and her achievements reflect the direction science funding is going into the future.... I see biology as being the greatest area of scientific breakthroughs in the next generation" (New York Times, 9 March 1999). Later that year, in an editorial in the Boston Globe (28 December 1999), retired congressional leader Newt Gingrich noted, "Biology will be to the 21st century what physics was to the 20th." But will biomedical disciplines achieve this goal? We can be assured that at least in medicine, with its strong union, and in areas like molecular biology, where there are very large groups of professional public policy staff members, there will be active, daily advocacy for investing in achieving these goals. The fate of organismal and integrative biology is far less secure. We have not accepted that we need to speak out with a common voice for our science.
For the most basic challenge to science-securing adequate research funds-the need for organized, sustained involvement in the policy arena is more pronounced than ever before. The business and industrial sectors have shifted their focus and their dollars to applied research. The federal investment in basic research has become the sole surviving source of funding for most of us. Of course, the primary support for research in organismal biology has almost always been from the National Science Foundation anyway, so the change in our fields has been less obvious. Nonetheless, more than ever, the support for basic research is dependent on federal dollars. Fortunately , this comes at a time of perhaps unprecedented support for basic research, at least from some quarters. For instance, in another editorial (Washington Post, 18 October 1999) Newt Gingrich pointed out, "The highest investment priority in Washington should be to double the federal budget for scientific research. No other federal expenditure would create more jobs and wealth or do more to strengthen our world leadership, protect the environment and promote better health and education for all Americans. For the security of our future, we must make this investment now."
The Clinton administration supported a plan for doubling the NSF budget over five years. Many in Congress support this effort as well. Senators Bill Frist (R-TN) and John D. Rockefeller IV (D-WV) and Representatives Heather Wilson (R-NM) and Rush Holt (D-NJ) sponsored legislation to double the federal civilian research investment across all federal research agencies, including NSF, EPA, DOE, and NASA, over 11 years. Christopher Bond (R-MO), then chair, and ranking Democrat (and now chair) Barbara Mikulski (MD), of the Senate appropriations subcommittee for VA, HUD and Independent Agencies-the subcommittee that determines the NSF budget-wrote to the Senate majority and minority leaders, stating, "Just as we have worked effectively to double the NIH budget over five years, we believe it is now time to launch a parallel effort to double the budget of the NSF over five years." Thanks to a broad-based effort, including strong advocacy by our colleagues with organized, professional public policy staffs, the Congress eventually enacted a much larger increase-13.6%-for fiscal year 2001. The situation for fiscal year 2002 was less rosy. The White House proposed an increase of only 1.3% for NSF, with a 0.5% decrease for the NSF biology directorate. The House proposed a 9% increase, while the Senate would have appropriated only 5.5% above the previous year.* Our legislative leaders ordinarily do not make changes without great support from their constituents; the force of a unified front from scientists across disciplines lobbying for general support of science can have a similar effect.
In a related and troubling development, when there are increases in science support from Congress, much of it comes packed in pork barrels rather than as investment in meritbased basic research categories. The peer-reviewed system that assures that the most important research is conducted the right way is endangered by the game of earmarking funds for favored research centers in the legislator's home state. An organized effort by biologists and biological societies is needed to address these issues. Not only do we need to do our part in the public policy area, rather than leaving it to our colleagues in other scientific disciplines, but we also need to be sure that the voice of organismal and integrative biology is heard.
Many other pressing public policy issues demand our attention-some even strike at the heart of what we as scientists do and know. The recent and continuing attacks on the teaching of evolution demonstrate how critical it is for us to participate in public policy discussions. We have a leadership obligation in our fields-to our societies and to the publicto be sure that science curricula are based on the accepted paradigms in our disciplines. How do we do that effectively? Certainly the coalitions urging evolution-free science curricula or equal time for creationism in Kansas, Oklahoma, and other states understand the power of collective action. This continuing campaign to discredit evolution or downgrade it to the status of an alternative theory that should be taught alongside creationism and intelligent design is manifest on Capitol Hill by the lobbying activities of the Discovery Institute, a well-funded and highly organized think tank and advocacy organization.
The community of scientists in general has reacted well, and with considerable energy, to both the budget and science curriculum issues. The former chair of the Kansas board of education, Linda Holloway, blamed her defeat in the recent primary election on "this elite group in Washington that have an agenda, the National Academy of Sciences and the other science groups" (New York Times, 3 August 2000). Professional societies in organismal biology contributed to these efforts too, but not with the strength of our sister societies with full-time professionals. So what are we missing by depending largely on volunteer officers and volunteer public policy committees to inform us and galvanize our actions? Actions by individuals-talks to schools, to the Rotary Club, the local library; interviews in the local newspaper; conversations with local politicians-are important, and that is where it all must begin. Letters from volunteer society public policy committees or presidents speaking out also add weight, especially from societies with substantial membership. These actions alone are not enough, however. Individual actions do not grant organismal and integrative biologists the opportunity to inform the public, press, Congress, granting agencies, education policy-setting bodies, and regulatory agencies about the excitement in our fields and our needs and priorities. For this kind of information, our colleagues in other areas of science benefit most from staff paid to know what is going on in the government, in Congress, in the White House, and in regulatory agencies.
Disdain and fear of lobbying combine to set up a barrier to both individual and concerted action. The disdain comes from some ill-defined sense that public advocacy for our fields somehow tarnishes us as scientists. We in organismal biology mostly seem to be descendants of Lake Wobegon stock for whom public advocacy is just too much like boasting. But if we believe in what we do, why shouldn't we try to convince others of its importance? Our colleagues in other disciplines have long since abandoned the notion that they will be sullied by speaking out. It is time for us to come to that same realization. Again, in the Boston Globe (28 December 1999), Newt Gingrich made a strong statement about both basic research and the responsibility of scientists: "The fate of our country may well depend on whether or not scientists recognize that they have real responsibilities as citizens.... The fact is that no one else is as qualified to make the case for increased funding in science research and reform of science education. Without a continued commitment to funding scientific research and development and a successful reform of science education, it is very unlikely that the United States will maintain the momentum it has created over the last 60 years." (Blockstein 2001 ):"It is also safe to say that, although legislation alone will not conserve biodiversity, without politics, there will be no biodiversity." He exhorts biologists to speak for themselves:"If conservation biologists are not advocates for biodiversity, who will be?" Blockstein characterizes scientists as possessors of specialized expert knowledge, practiced critical thinking, experience with data and interpretations, credibility through scientific objectivity, and independence. Given these attributes, he concludes that "it is our scientific responsibility to contribute them to the political process. Most scientists are recipients of public funds for...research. As part of the social contract by which society supports science, we are obligated to provide some payback sharing the fruits of our knowledge with society.... The application of science involves use of judgment. Yet, who is better qualified to provide this judgment than scientists?" These are compelling arguments for advocacy-this seems like the right thing for the science we believe in so deeply.
Another encumbrance is our mistaken assumption about lobbying, which is but one form of advocacy. The governing councils of the scientific societies I have been involved with often question whether scientists can lobby. Because we are conservative groups when it comes to the trust granted in us to manage societies, we usually decide that we cannot or should not lobby, often mistakenly concluding that tax-exempt organizations will lose that status if they lobby. But we are wrong: Tax-exempt organizations may lobby, but may not invest a substantial amount of the organization's expenditures in lobbying. By filing IRS form 5768 under section 501(h) of the Internal Revenue Code 501(c)(3), our societies may invest far more than most would chose to pay for lobbying (i.e., up to 20% of the first $500,000 of society expenditures, plus smaller proportions for further expenditures). Furthermore, much of what we might consider lobbying, such as broadly informing the membership of societies about legislative or governmental issues, is not considered lobbying. In "Policy Basics," a paper prepared for AIBS members, the AIBS Public Policy Office provides details regarding what does and does not constitute lobbying (to get a copy, contact AIBS Senior Public Policy Representative Ellen Paul by e-mail at epaul@aibs.org). The following activities do not constitute lobbying:
• Making available the results of nonpartisan analysis, study, or research
• Examining and discussing broad social, economic, and similar problems
• Providing technical advice or assistance to a governmental body or to a committee or other subdivision thereof in response to a written request by that body or subdivision
• Appearing before or communicating with any legislative body about a possible decision of that body that might affect the existence of the organization, its powers and duties, its tax-exempt status, or the deduction of contributions to the organization
• Communicating with a government official or employee (unless the principal purpose of the communication is to influence legislation)
• Transmitting information or advocating positions to society members So, if advocacy is a good thing, how do we go about it? The AIBS Public Policy Office summarizes a number of kinds of public policy activities:
• Direct contact with legislators-via personal visits and letters-on issues of interest to the society and its members. The staff might arrange for a member to testify as an expert witness to a congressional committee, organize workshops or briefings for members of Congress and their staff, coordinate visits by members to legislators while Congress is in session, or arrange visits to representatives in their home district visits.
• Track the issues that affect the conduct of science or issues in which science plays a significant role, and inform the membership of significant developments. This is a critical role for the public policy office. AIBS, for instance, provides biweekly policy updates by e-mail that are also posted on the AIBS website.
• Work with established coalitions of scientific societies.
• Submit comments to regulatory agencies on rules and regulations that affect scientific research, such as changes to animal welfare regulations, access by biologists to the National Wildlife Refuges, and research integrity policies. There is also a need for scientific organizations to supply relevant scientific information to these agencies when they make rules pertaining to the environment.
• Provide media with news briefings and news releases, based on relevant work by society members.
To what extent do societies now employ such professionals? Table 1 summarizes public policy for a range of the societies associated with AIBS, and includes the programs in some other areas of science for comparison. Smaller societies tend not to have professional public policy help. Examination of the first several entries in the table shows, not surprisingly, that existing public policy activities are performed by elected volunteer officers or appointed volunteer committees. These are represented by such societies as the Botanical Society of America (BSA) and the Society for Integrative and Comparative Biology, societies with fewer than 4,000 members, the kind of societies that make up the bulk of the 83 member societies under the AIBS umbrella.
Then there is a middle category of somewhat larger societies associated with AIBS, such as the Ecological Society of America (ESA) and the American Society of Plant Physiologists. These two are representative of societies large enough to have Washington offices, several paid staff, and small professional public policy offices. An expanded AIBS public policy office could serve to help build coalitions among such groups and provide services to the smaller groups.
Organismal biology as a whole does not compare favorably in public policy organization or effort with our sister areas in science. The Federation of American Societies of Experimental Biology (FASEB), with only 21 organizations under its umbrella (focusing on biomedical biology), expends about $1.5 million a year for a public policy office with eight professionals (who also coordinate public policy activities among member societies). The American Institute of Physics (AIP, the model for the formation of the AIBS federation half a century ago) has over 120,000 members, but apparently only a small public policy office. However, most AIP public policy activities constitute coordination among the professionals in the 29 members and affiliates. In contrast, the American Chemical Society (ACS, a scientific society with over 161,000 members) supports a very vigorous public policy office with 18 full-time professionals and nearly a $2 million budget. The American Association for the Advancement of Science is the leader in public policy, not inappropriate for the organization that represents science in general, with over $5 million invested in a directorate with over 40 staff members. Finally, the largest umbrella-really an umbrella of umbrellas-the Council of Scientific Society Presidents (CSSP), representing a collective membership of over 1.25 million scientists in the individual societies, exists primarily for public policy efforts through coordination of individual society presidents.
It must be obvious that size matters. Bigger societies, the larger "umbrellas," do the job much better. But size does not have to be achieved via a single membership like the ACS. Coalitions are the much more common paradigm: AIP and FASEB are coalitions, as is CSSP-its mission is focused en- The Public Policy Office keeps close tabs on developments in research policy. This year, AIBS submitted extensive comments on the proposed federal data quality guidelines, which might well have had a chilling effect on the dissemination of scientific information by government agencies. Our comments, along with those of 50 other scientific organizations and academic institutions, helped persuade the Office of Management and Budget to make significant changes in the guidelines that will minimize the negative consequences of the policy.
When the Smithsonian proposed to close its Conservation and Research Center, AIBS was in the lead in protesting this decision, which was quickly reversed in response to the public outcry. We continue to follow closely the Smithsonian's efforts to reorganize its scientific research program.
Warding off attacks on the teaching of evolution requires constant vigilance. We have been working diligently to persuade Congress to drop an amendment to the Elementary and Secondary Education Act characterizing biological evolution as a controversial subject; the amendment would promote the teaching of intelligent design or even its ancestral formcreationism-in the public schools. At the state level, we worked to help defeat procreationism or antievolution legislation and science standards in Hawaii and Pennsylvania.
AIBS member societies often request assistance in developing their own public policy initiatives. The AIBS public policy representatives review society position statements and help to develop effective distribution strategies. They also help societies present congressional briefings.
Through all of these efforts, together with the biweekly science policy updates and the Washington Watch column in BioScience, the AIBS Public Policy Office has made great strides in fulfilling the goal set for AIBS at the 1999 AIBS Presidents' Summit-to give its member societies a strong, collective voice.
-ELLEN PAUL AIBS Public Policy Representative (E-mail: epaul@aibs.org)
The AIBS Public Policy Office: Look What We've Done for You Lately!
